Q&A: Adjusting to the Hybrid Meeting Landscape in the Health and Science Industry
LaVoie Health Science Blog
JULY 15, 2021
With a 26-year background in life sciences, Sharon specializes in the development and execution of strategic investor relations programs for public and pre-IPO companies in the life sciences sector. His broad therapeutic area experience is applied in specialty, orphan, and rare disease markets.
52 
Let's personalize your content